137 related articles for article (PubMed ID: 2198415)
41. Relapses in leprosy patients treated with rifampicin plus dapsone after varying periods of dapsone monotherapy.
Li HY; Ran SP; Weng XM; Li TG; Deng XH; Li FT
Indian J Lepr; 2001; 73(1):1-10. PubMed ID: 11326592
[TBL] [Abstract][Full Text] [Related]
42. Problems of multidrug therapy.
Ramu G
Indian J Lepr; 1991; 63(3-4):435-45. PubMed ID: 1804896
[No Abstract] [Full Text] [Related]
43. Incidence of leprosy in school-children and their family members in Berhampur.
Sahoo A; Singh PC; Pattnaik S; Singh N
Indian J Lepr; 2002; 74(2):137-43. PubMed ID: 12708732
[TBL] [Abstract][Full Text] [Related]
44. Paucibacillary primary dapsone resistance--a case report.
Deenabandhu A; Kothandapani VG
Indian J Lepr; 1988 Jan; 60(1):100-5. PubMed ID: 3060544
[TBL] [Abstract][Full Text] [Related]
45. Dapsone induced methaemoglobinaemia.
Diwan SK; Sharma AK; Jain AP; Gupta OP; Jajoo UN
Indian J Lepr; 1991; 63(1):103-5. PubMed ID: 1919080
[No Abstract] [Full Text] [Related]
46. A high incidence of viable Mycobacterium leprae in post-MDT recurrent lesions in tuberculoid leprosy patients.
Shetty VP; Wakade A; Antia NH
Lepr Rev; 2001 Sep; 72(3):337-44. PubMed ID: 11715280
[No Abstract] [Full Text] [Related]
47. Half a Century in Hiding: A Unique Case of Tuberculoid Leprosy with an Unprecedented Incubation Period.
Rajani AJ; Raval DM; Chitale RA; Kempaiah P; Elwasila SM; Durvasula R; Oring J
Am J Case Rep; 2024 Feb; 25():e942048. PubMed ID: 38351602
[TBL] [Abstract][Full Text] [Related]
48. Histological changes in tuberculoid leprosy after fixed duration multidrug therapy for six months.
Lavania RK; Girdhar A; Girdhar BK; Desikan KV
Acta Leprol; 1990; 7(2):169-74. PubMed ID: 2220301
[TBL] [Abstract][Full Text] [Related]
49. Dapsone syndrome: an incomplete form.
Jaswal R; Thami GP; Kanwar AJ
Indian J Lepr; 1998; 70(2):229-30. PubMed ID: 9724867
[No Abstract] [Full Text] [Related]
50. Lymphocyte proliferation, IFN-gamma production and limiting dilution analysis of T-cell responses to ICRC and Mycobacterium leprae antigens in leprosy patients.
Shinde SR; Chiplunkar SV; Butlin R; Samson PD; Deo MG; Gangal SG
Int J Lepr Other Mycobact Dis; 1993 Mar; 61(1):51-8. PubMed ID: 8326181
[TBL] [Abstract][Full Text] [Related]
51. An evaluation of clinical and histopathological status in paucibacillary leprosy patients after completion of fixed duration therapy.
Mathew D; Kishore BN; Shwethadri GK; Sukumar ; Shetty NJ
Indian J Lepr; 2004; 76(1):11-8. PubMed ID: 15527055
[TBL] [Abstract][Full Text] [Related]
52. Immunotherapy of lepromin-negative borderline leprosy patients with low-dose Convit vaccine as an adjunct to multidrug therapy; a six-year follow-up study in Calcutta.
Chaudhury S; Hajra SK; Mukerjee A; Saha B; Majumdar V; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1997 Mar; 65(1):56-62. PubMed ID: 9207754
[TBL] [Abstract][Full Text] [Related]
53. [Immuno-allergic accidents with rifamipcin].
Flageul B; Wagner L; Cottenot F
Acta Leprol; 2001-2002; 12(2):71-8. PubMed ID: 12136739
[TBL] [Abstract][Full Text] [Related]
54. Two microbiological relapses in a patient with lepromatous leprosy.
Chakma JK; Girdhar A; Natrajan M; Kumar A; Girdhar BK
Lepr Rev; 2008 Sep; 79(3):331-4. PubMed ID: 19009984
[TBL] [Abstract][Full Text] [Related]
55. Why relapse occurs in PB leprosy patients after adequate MDT despite they are Mitsuda reactive: lessons form Convit's experiment on bacteria-clearing capacity of lepromin-induced granuloma.
Chaudhuri S; Hajra SK; Mukherjee A; Saha B; Mazumder B; Chattapadhya D; Saha K
Int J Lepr Other Mycobact Dis; 1998 Jun; 66(2):182-9. PubMed ID: 9728450
[TBL] [Abstract][Full Text] [Related]
56. Analysis of a novel multiplex polymerase chain reaction assay as a sensitive tool for the diagnosis of indeterminate and tuberculoid forms of leprosy.
Chaitanya VS; Cuello L; Das M; Sudharsan A; Ganesan P; Kanmani K; Rajan L; Ebenezer M
Int J Mycobacteriol; 2017; 6(1):1-8. PubMed ID: 28317797
[TBL] [Abstract][Full Text] [Related]
57. Relapses after a single dose of rifampin in skin-smear negative multibacillary patients after dapsone monotherapy.
Jamet P; Blanc L; Fayne OC; Traore I; Bobin P
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):209-14. PubMed ID: 8046259
[TBL] [Abstract][Full Text] [Related]
58. Pattern of bacillary clearance in multibacillary leprosy patients with multidrug therapy.
Kumar A; Girdhar A; Girdhar BK
Acta Leprol; 2003; 12(3):123-8. PubMed ID: 15040703
[TBL] [Abstract][Full Text] [Related]
59. Neuritic leprosy: epidemiology and therapeutic responsiveness.
Talwar S; Jha PK; Tiwari VD
Lepr Rev; 1992 Sep; 63(3):263-8. PubMed ID: 1406021
[TBL] [Abstract][Full Text] [Related]
60. Brazilian clinical trial of uniform multidrug therapy for leprosy patients: the correlation between clinical disease types and adverse effects.
Gonçalves Hde S; Pontes MA; Bührer-Sékula S; Cruz R; Almeida PC; Moraes ME; Penna GO
Mem Inst Oswaldo Cruz; 2012 Dec; 107 Suppl 1():74-8. PubMed ID: 23283457
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
